Diabetes is an insidious global threat. Rising obesity, urbanization, and the high cost of healthy living fuel an unprecedented surge in type 2 diabetes, especially in poorer countries. Many face diets dominated by affordable, highly processed foods while struggling to afford better choices, with climate change worsening food insecurity. Access to diagnosis and treatment is also often limited — leaving millions undiagnosed or untreated and bringing heavy personal and economic burdens.
There's a 40% chance that there will be an FDA-approved cure for Type 1 diabetes before Jan. 1, 2032, according to the Metaculus prediction community.
There'sWith over 800M people now living with diabetes worldwide, a 40%bold chanceshift thatin theretreatment willis beoverdue. anRather FDAthan the current one-approvedsize-fits-all cureprescriptions, fora Typepersonalized, 1precision-based diabetesapproach before— Jantailoring medications to each individual's unique genetics and underlying causes — is essential. 1,This 2032strategy promises better health outcomes and reduced costs, accordingempowering healthcare systems to address the Metaculusroot predictioncauses communityof diabetes and to meet the diverse needs of patients.